Stocktoria
Acumen Pharmaceuticals, Inc. ABOS
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-07-01
Acumen Pharmaceuticals, Inc. statistics & valuation
Market cap$170.5M
P / B2.4×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -98.8% | -42.8% | -16.9% | -21.8% | -43.7% |
| Return on equity | -172.3% | -56.3% | -19.6% | -22.7% | -44.7% |
| Debt / equity | 0.32× | 0.16× | 0.11× | 0.00× | — |
| Current ratio | 4.07 | 6.46 | 19.01 | 23.08 | 38.60 |
Source: SEC EDGAR filings · CIK 0001576885 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.